Clinical Trials on Skin Bacteria in Australia

Total 2356 results

The University of Queensland
Merck Sharp & Dohme LLC

Withdrawn

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection (MERINO III)

Bacteremia Caused by Gram-Negative Bacteria

Spain, Australia, Singapore, Italy, Saudi Arabia
Azora Therapeutics Australia Pty Ltd

Completed

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

Australia
Pfizer

Completed

An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

Bacterial Infections | Staphylococcal Skin Infections | Staphylococcal Infections | Staphylococcal Vaccines | Immunotherapy, Active

Australia
Royal North Shore Hospital

Unknown

Citriodiol® and Impetigo

Impetigo

Australia
The University of Queensland
Metro North Hospital and Health Service; Pathology Queensland

Recruiting

T2 and SeptiCyte RAPID Duration Project

Bacteremia

Australia
Holdsworth House Medical Practice
Rigel Pharmaceuticals

Completed

Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa

Hidradenitis Suppurativa

Australia
Menzies School of Health Research
Murdoch Childrens Research Institute; University of Melbourne; Cooperative Research...

Completed

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory (EAHSP)

Streptococcal Infections | Scabies | Pyoderma | Impetigo

Australia
Murdoch Childrens Research Institute
Sydney Children's Hospitals Network; Royal Children's Hospital; Monash Health; Royal...

Not yet recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) (VANCAPP)

Infections | Sepsis | Bacteremia

Australia
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Infections, Meningococcal

Australia
Outcome Rea
Institut National de la Santé Et de la Recherche Médicale, France; European... and other collaborators

Completed

Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care (EurobactII)

Sepsis | Bacteremia | Hospital Acquired Condition | Resistance Bacterial

Australia, France
Murdoch Childrens Research Institute
University of Otago; Sydney Children's Hospitals Network; Royal Children's Hospital and other collaborators

Completed

Improving Dosing of Vancomycin in Young Infants With Infections (VANCAPP)

Sepsis | Bacteremia | Infection

Australia
Murdoch Childrens Research Institute
Royal Children's Hospital; Royal Hospital For Women

Completed

RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates

Sepsis | Bacteremia | Infection

Australia
GlaxoSmithKline

Completed

A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

Infections, Bacterial

Australia
GlaxoSmithKline

Terminated

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Infections, Bacterial

Australia
Medical University Innsbruck
Austrian Society of Periodontology

Completed

The Impact of Material on Microbiota in Association With Tongue and Lip Piercing

Bacteremia

Austria
GlaxoSmithKline

Completed

To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

Healthy Subjects | Infections, Bacterial

Australia
CSL Behring

Completed

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Hidradenitis Suppurativa | Palmoplantar Pustulosis

Denmark, Australia, Germany
GlaxoSmithKline

Terminated

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416

Infections, Bacterial | Bacterial Infection

Australia
Eli Lilly and Company

Completed

A Study of LY3041658 in Adults With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States, Australia
GPN Vaccines

Recruiting

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Pneumococcal Infections

Australia
GPN Vaccines

Recruiting

Extension Safety and Immunogenicity Study of GPNV-001

Pneumococcal Infections

Australia
University of Melbourne
Radboud University Medical Center; Sunnybrook Health Sciences Centre; UMC Utrecht and other collaborators

Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial (SNAP)

Staphylococcus Aureus Bacteremia

Australia, New Zealand, Canada, Singapore, Netherlands, Israel
Qpex Biopharma, Inc.
Shionogi Inc.; Biomedical Advanced Research and Development Authority

Recruiting

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

Bacterial Infections

Australia
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects

Bacterial Infections

Australia
Resistell AG

Recruiting

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia (PHENOTECH-1)

Bacteremia Sepsis

Austria, Spain, Switzerland
Bayer

Completed

Avelox in Complicated Skin and Skin Structure Infections (ARTOS)

Skin Diseases, Bacterial

Germany, Indonesia, Korea, Republic of, Saudi Arabia, Philippines, Taiwan, Austria, Bulgaria, Slovenia, Egypt, Greece, Pakistan
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects

Bacterial Infections | Healthy Volunteers

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Bacterial Infections | Healthy Volunteers

Australia
Pfizer

Completed

Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections

Gram-negative Bacterial Infection

Australia
Medical University of Graz

Completed

Clinical Evaluation of Novel Biomarkers in Patients With Septicemia (NOBIS)

Sepsis | Fungemia | Bacteremia

Austria
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

Meningitis, Meningococcal

Australia
University of Adelaide
University of Sydney; The University of New South Wales; Menzies School of Health... and other collaborators

Recruiting

Immunisation for Adolescents Against Serious Communicable Diseases (B Part of it NT)

Gonorrhea | Meningococcal Disease

Australia
University of Adelaide
SA Health

Completed

South Australian Meningococcal B Vaccine Herd Immunity Study (B Part of It)

Meningococcal Disease

Australia
Meiji Seika Pharma Co., Ltd.

Completed

A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595

Bacterial Infections | Healthy Volunteers

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects

Bacterial Infections | Healthy Volunteers

Australia
Armata Pharmaceuticals, Inc.
United States Department of Defense

Recruiting

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (diSArm)

Bacteremia | Staphylococcus Aureus | Staphylococcus Aureus Bacteremia | Bacteremia Due to Staphylococcus Aureus | Bacteremia Staph

United States, Australia
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Bacterial Infections

Australia, United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

Bacterial Infections

Australia, United States
Royal Brisbane and Women's Hospital
The University of Queensland

Completed

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT (CT-PK)

Gram-Negative Bacterial Infections

Australia
Bugworks Research Inc.
Avance Clinical Pty Ltd.

Terminated

The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers

Bacterial Infections | Infectious Diseases

Australia
GlaxoSmithKline

Completed

Single Dose Escalation First Time in Human PK Study

Infections, Bacterial

Australia
Bugworks Research Inc.
Avance Clinical Pty Ltd.

Completed

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers

Bacterial Infections | Infectious Diseases

Australia
GlaxoSmithKline

Completed

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Infections, Bacterial

Australia
Canadian Scleroderma Research Group
Canadian Institutes of Health Research (CIHR)

Unknown

The Small Intestine Bacterial Overgrowth Study Pilot (SIBO)

Systemic Sclerosis | Small Intestinal Bacterial Overgrowth

United States, Australia
The University of Queensland

Withdrawn

Penicillin Against Flucloxacillin Treatment Evaluation (PANFLUTE)

Staphylococcus Aureus

Australia
Clinuvel Pharmaceuticals Limited

Completed

Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

Polymorphic Light Eruption (PLE)

Austria, Australia, United Kingdom
Okogen

Active, not recruiting

OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis (RUBY)

Adenoviral Conjunctivitis

Australia
GlaxoSmithKline

Completed

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Meningitis, Meningococcal

Australia, Germany
Sanofi

Recruiting

Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis

Chile, Canada, United States, Australia, Portugal, Hungary, Italy
AbbVie

Completed

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (DETERMINED 1)

Hidradenitis Suppurativa

United States, Australia, Canada, France, Germany, Japan, Netherlands, Spain

Clinical Trials on Skin Bacteria in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations